Tazarotene
- Level
- Commodity
- Parent
- 51241200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51241219This classification denotes a retinoic acid agent with the molecular formula C21H21NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81BDR9Y8PS, chemically known as 3-pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2h-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester but generally known as tazarotene, which bears US NIH Compound Identifier 5381. European Medicines Agency schedules Tazarotene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10844MIG. The term TAZAROTENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules tazarotene in its Anatomical Therapeutic Chemical (ATC) Classification. TAZAROTENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tazarotene under HS 29349990 and SITC 51579. As of Q4 2014, TAZAROTENE remains the US FDA Preferred Term for this commodity. Tazarotene bears US NLM identifiers UMLS ID C0288792 and NCI Concept Code C29487. SMILES: S1CCC(C2C1CCC(C2)C#CC1NCC(CC1)C(=O)OCC)(C)C.
Same parent
Under 51241200 · 46Activities that produce or sell this
KBLI · 9Inherited from family 51240000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.